Olema Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its pipeline includes drug candidates such as OP-1250 and OP-3136, aiming to improve outcomes for women living with cancer.
The posting states responsibilities including 'implementation of new accounting systems and ongoing maintenance' as part of rolling out new accounting policies to meet SOX requirements.